GURUFOCUS.COM » STOCK LIST » Technology » Software » NRGene Technologies Ltd (XTAE:NRGN) » Definitions » Capex-to-Revenue

NRGene Technologies (XTAE:NRGN) Capex-to-Revenue : 0.93 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NRGene Technologies Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

NRGene Technologies's Capital Expenditure for the six months ended in Dec. 2023 was ₪-2.98 Mil. Its Revenue for the six months ended in Dec. 2023 was ₪3.19 Mil.

Hence, NRGene Technologies's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.93.


NRGene Technologies Capex-to-Revenue Historical Data

The historical data trend for NRGene Technologies's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NRGene Technologies Capex-to-Revenue Chart

NRGene Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
- 0.25 0.54 0.83

NRGene Technologies Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial 0.42 0.59 0.49 0.76 0.93

Competitive Comparison of NRGene Technologies's Capex-to-Revenue

For the Software - Application subindustry, NRGene Technologies's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NRGene Technologies's Capex-to-Revenue Distribution in the Software Industry

For the Software industry and Technology sector, NRGene Technologies's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where NRGene Technologies's Capex-to-Revenue falls into.



NRGene Technologies Capex-to-Revenue Calculation

NRGene Technologies's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-6.245) / 7.497
=0.83

NRGene Technologies's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-2.978) / 3.192
=0.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NRGene Technologies  (XTAE:NRGN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


NRGene Technologies Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of NRGene Technologies's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


NRGene Technologies (XTAE:NRGN) Business Description

Traded in Other Exchanges
N/A
Address
5 Golda Meir Street, Ness-Ziona, ISR, 7403649
NRGene Technologies Ltd is engaged in the development of artificial intelligence-based software for the analysis of genetic information in order to improve species of plants and animals.

NRGene Technologies (XTAE:NRGN) Headlines

No Headlines